CARIS LIFE SCIENCES, INC. Shares Outstanding
CARIS LIFE SCIENCES, INC. (CAI) had Shares Outstanding of 282.58 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-05
- 2026-06-30: Shares outstanding (split-adjusted) 282.58M shares; Shares authorized (split-adjusted) 2.80B shares.
- 2026-03-31: Shares outstanding (split-adjusted) 282.65M shares; Shares authorized (split-adjusted) 2.80B shares.
- 2025-12-31: Shares outstanding (split-adjusted) 282.53M shares; Shares authorized (split-adjusted) 2.80B shares.
- 2025-09-30: Shares outstanding (split-adjusted) 282.10M shares; Shares authorized (split-adjusted) 2.80B shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 282.58M shares 10-Q · filed 2026-08-05 | 2.80B shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 282.65M shares 10-Q · filed 2026-05-08 | 2.80B shares 10-Q · filed 2026-05-08 |
| 2025-12-31 | 282.53M shares 10-Q · filed 2026-08-05 | 2.80B shares 10-Q · filed 2026-08-05 |
| 2025-09-30 | 282.10M shares 10-Q · filed 2025-11-05 | 2.80B shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 281.09M shares 10-Q · filed 2025-08-12 | 2.80B shares 10-Q · filed 2025-08-12 |
| 2025-06-20 | (m) | 2.80B shares 10-K · filed 2026-03-03 |
| 2024-12-31 | 36.50M shares 10-K · filed 2026-03-03 | 1.15B shares 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |